This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days.

Stem Cell Innovations, Inc. (SCLL) SWOT Analysis report provides you a strategic analysis and detailed overview of the company’s businesses and operations.

In this report, our analysts reveal the company’s business strategy, strengths, weakness, opportunities and threats and detailed information such as :
- Key events associated with the company,
- Major products, services and brands of the company,
- Key competitors,
- Key executives, biographies and employment history,
- Personnel heading key departments and functions,
- Important locations and subsidiaries
- Financial analysis and ratios based on the annual financial statements published by the company including a 5 years history.
- Interim ratios for the last five interim periods

You get also in deepth information about Stem Cell Innovations, Inc. (SCLL) operations to identify potential customers, partners and suppliers. Stem Cell Innovations, Inc. (SCLL) business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Table Of Contents


Data table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 3
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Year, from 2005 to 2011 4
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare Deals By Type, from 2005 to 2011 5
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal By Region, from 2005 to 2011 6
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Therapy Area, from 2005 to 2011 7
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, from 2005 to 2011 8
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Licensing Deals, Deals By Year Vs Deal Value Vs Upfront Payment, from 2005 to 2011 9
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal Summary, from 2005 to 2011 10
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal Details 11
Partnerships 11
High Q Foundation Enters Into Co-Development Agreement With Stem Cell 11
Stem Cell Enters Into Collaboration Agreement With TNO 12
Stem Cell Innovations Enters Into Agreement With ALS 13
Licensing Agreements 14
Pluristem Enters Into Licensing Agreement With Stem Cell Innovations 14
Pluristem Enters Into Licensing Agreement With Stem Cell Innovations 15
Divestiture - Assets 16
Hemispherx Biopharma Takes Over Royalty Interest From Stem Cell Innovations 16
Debt Offering 17
Stem Cell Innovations Completes Private Placement Of Convertible Note For US$ 1 Mln 17
Acquisition 18
Stem Cell Innovations Takes Over Amphioxus Cell 18
Key Competitors 19
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Product News 21
April 10, 2007: Stem Cell Innovations Patents On Pluripotent Cells Cited By The U.S. Patent And Trademark Office As Prior Art, Pre-Dating The Warf And Thomson Core Embryonic Stem Cell Patents 21
January 09, 2007: Stem Cell Innovations Announces Issuance Of Fundamental Human Stem Cell Patent 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22


List of Tables

Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Major development, 2006 1
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Year, from 2005 to 2011 1
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal By Region, from 2005 to 2011 1
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Therapy Area, from 2005 to 2011 1
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal Summary, from 2005 to 2011 1
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Year, from 2005 to 2011 4
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare Deals By Type, from 2005 to 2011 5
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal By Region, from 2005 to 2011 6
Stem Cell Innovations, Inc., Deals By Therapy Area, from 2005 to 2011 7
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, from 2005 to 2011 8
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, from 2005 to 2011 8
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Licensing Deals, Deals By Year Vs Deal Value Vs Upfront Payment, from 2005 to 2011 9
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Licensing Deals, Deals By Year Vs Deal Value Vs Upfront Payment, from 2005 to 2011 9
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal Summary, from 2005 to 2011 10
High Q Foundation Enters Into Co-Development Agreement With Stem Cell 11
Stem Cell Enters Into Collaboration Agreement With TNO 12
Stem Cell Innovations Enters Into Agreement With ALS 13
Pluristem Enters Into Licensing Agreement With Stem Cell Innovations 14
Pluristem Enters Into Licensing Agreement With Stem Cell Innovations 15
Hemispherx Biopharma Takes Over Royalty Interest From Stem Cell Innovations 16
Stem Cell Innovations Completes Private Placement Of Convertible Note For US$ 1 Mln 17
Stem Cell Innovations Takes Over Amphioxus Cell 18
Stem Cell Innovations, Inc., Key Executives 19


List of Figures

Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals by Type, from 2005 to 2011 1
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Year, from 2005 to 2011 4
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals by Type, from 2005 to 2011 5
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal By Region, from 2005 to 2011 6
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Therapy Area, from 2005 to 2011 7

Companies mentioned
Opexa Therapeutics, Inc.
Aileron Therapeutics, Inc.
Arteriocyte, Inc.
Imgenex Corp.
GeriGene Medical Corporation

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.